Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Myovant Sciences Ltd (NY: MYOV ) N/A UNCHANGED Last Price Updated: 7:00 PM EST, Mar 9, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Myovant Sciences Ltd < Previous 1 2 3 4 5 Next > The 2 Best Pharma Stocks to Buy on Dips June 23, 2021 Because the COVID-19 pandemic is under control in most major economies, the hype surrounding vaccine producers is gradually tapering off. Via Talk Markets Exposures COVID-19 3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer June 05, 2021 The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic. Via Talk Markets Exposures COVID-19 Looking Into Myovant Sciences's Return On Capital Employed June 02, 2021 During Q4, Myovant Sciences (NYSE:MYOV) brought in sales totaling $24.61 million. However, earnings decreased 1.75%, resulting in a loss of $76.95 million. Myovant Sciences... Via Benzinga Myovant - Pfizer's Uterine Fibroids Treatment Wins FDA Approval May 27, 2021 The FDA has approved Myovant Sciences Ltd (NYSE: MYOV) and Pfizer Inc’s (NYSE: PFE) relugolix combined with estradiol and norethindrone acetate for... Via Benzinga Exposures Product Safety Myovant Sciences' Relugolix Combo Tablet For Uterine Fibroids Scores EMA Backing For Approval May 21, 2021 European Medicines Agency's advisory committee issued a positive opinion recommending the approval of Myovant Sciences Ltd's (NYSE: MYOV) Ryeqo (... Via Benzinga Earnings Scheduled For May 11, 2021 May 11, 2021 Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... Via Benzinga The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs May 27, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... Via Benzinga Exposures COVID-19 Myovant Stock Is Trading Lower After FDA Slapped Clinical Hold On Relugolix Combo Study May 19, 2021 Myovant Sciences Ltd (NYSE: MYOV) has received a partial clinical hold on its SERENE study (MVT-601-050) from the FDA. The Phase 3 study was evaluating relugolix... Via Benzinga Exposures Product Safety Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript May 11, 2021 MYOV earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial 9 Health Care Stocks Showing Unusual Options Activity In Today's Session May 11, 2021 This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... Via Benzinga Return On Capital Employed Overview: Myovant Sciences May 11, 2021 Myovant Sciences (NYSE:MYOV) reported Q4 sales of $24.61 million. Earnings fell to a loss of $76.95 million, resulting in a 1.75% decrease from last quarter. In Q3, Myovant... Via Benzinga Myovant Sciences: Q4 Earnings Insights May 11, 2021 Shares of Myovant Sciences (NYSE:MYOV) moved higher by 4.5% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 21.... Via Benzinga The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings May 11, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... Via Benzinga Exposures COVID-19 Product Safety The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings May 09, 2021 Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... Via Benzinga Exposures COVID-19 Product Safety < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.